Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Armin Böhmer"'
Autor:
Jutta Bergler-Klein, Peter P. Rainer, Markus Wallner, Marc-Michael Zaruba, Jakob Dörler, Armin Böhmer, Tamara Buchacher, Maria Frey, Christopher Adlbrecht, Rupert Bartsch, Mariann Gyöngyösi, Ursula-Maria Fürst
Publikováno v:
Wiener klinische Wochenschrift. 134(17-18)
SummarySurvival in cancer is continuously improving due to evolving oncological treatment. Therefore, cardiovascular short-term and long-term side effects gain crucial importance for overall outcome. Cardiotoxicity not only presents as heart failure,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0cf16f7e669295d00147fabe780119a
https://pubmed.ncbi.nlm.nih.gov/35507087
https://pubmed.ncbi.nlm.nih.gov/35507087
Autor:
Marco Metra, Georgios Giannakoulas, Tuvia Ben-Gal, Fabrizio Morandi, Josep Comín-Colet, Armin Böhmer, Martín J. García-González, Matti Kivikko, Javier Segovia, István Édes, Francesco Fedele, Bojan Vrtovec, Gerhard Wikström, Piero Pollesello, Zaza Iakobishvili, Cândida Fonseca, Johann Altenberger, Alexander Parkhomenko, Robert H. G. Schwinger, Gerhard Pölzl, Kenneth Dickstein, S T Matskeplishvili, Fabrizio Oliva, Jiří Kettner, Markku S. Nieminen, Lars H. Lund, Monika Seidel, Apostolos Karavidas, Pertti Jääskeläinen, John Parissis
Publikováno v:
International Journal of Cardiology
Background The intravenous inodilator levosimendan was developed for the treatment of patients with acutely decompensated heart failure. In the last decade scientific and clinical interest has arisen for its repetitive or intermittent use in patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b61add7884df88e09696e24f1dc81e8f
http://hdl.handle.net/11379/457680
http://hdl.handle.net/11379/457680
